Labgenomics Co

Labgenomics Co Inventory Turnover

The Inventory Turnover Ratio of Labgenomics Co (084650.KQ) as of Oct 27, 2026 is 20.67. In the previous year, Inventory Turnover Ratio was 14.57 — a change of 41.92% (higher).

Inventory Turnover

20.67

YoY

41.92%

Last updated:

Inventory Turnover Ratio of Labgenomics Co is 2025 20.67 . Inventory Turnover Ratio of Labgenomics Co was 2024 14.57 . It decreases by 41.92% higher compared to the previous year.

The Labgenomics Co Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2018
35.24 KRW
Jan 1, 2019
27.87 KRW
Jan 1, 2020
19.37 KRW
Jan 1, 2021
28.59 KRW
Jan 1, 2022
27.54 KRW
Jan 1, 2023
15.35 KRW
Jan 1, 2024
14.57 KRW
Jan 1, 2025
20.67 KRW
The Labgenomics Co Inventory Turnover history
YEARInventory TurnoverYoY
20.67+41.92%
14.57-5.09%
15.35-44.28%
27.54-3.66%
28.59+47.59%
19.37-30.49%
27.87-20.92%
35.24+56.47%
22.52-6.66%
24.13+21.83%
19.80-37.65%
31.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labgenomics Co Stock analysis

What does Labgenomics Co do? LabGenomics Co., Ltd. generates revenue through the provision of in vitro diagnostic (IVD) products and services. The company offers general diagnostic check services, molecular diagnostic check services, and research and development services, alongside IVD products such as DNA chips and PCR kits. Its diagnostic services include examinations for breast cancer and colorectal cancer, while its biosensor solutions target point of care testing (POCT). Additionally, LabGenomics sells healthy food as part of its product portfolio. The primary buyers of LabGenomics' services are healthcare institutions requiring diagnostic support, including hospitals and clinics. The company's molecular diagnostic services and cancer examinations are particularly sought after by medical facilities focused on specialized testing. Healthcare providers also purchase its biosensor solutions for immediate testing at the point of care. LabGenomics' product segments include IVD services, IVD products like DNA chips and PCR kits, cancer examination services, and healthy food. The company's molecular diagnostic services and cancer testing are key revenue drivers, while its biosensor for POCT and healthy food offerings serve complementary market segments. Labgenomics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labgenomics Co stock

Inventory Turnover Ratio of Labgenomics Co is 20.67 in 2025.

Inventory Turnover Ratio of Labgenomics Co changed from 14.57 to 20.67, representing a 41.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio Labgenomics Co since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's Labgenomics Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Labgenomics Co

All Key Metrics — Labgenomics Co